{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T04:25:12Z","timestamp":1788582312097,"version":"build-2803163510"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2025,7,18]],"date-time":"2025-07-18T00:00:00Z","timestamp":1752796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,7,18]],"date-time":"2025-07-18T00:00:00Z","timestamp":1752796800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Microbiol Infect Dis"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1007\/s10096-025-05219-0","type":"journal-article","created":{"date-parts":[[2025,7,18]],"date-time":"2025-07-18T12:22:41Z","timestamp":1752841361000},"page":"2509-2514","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["A comparative study of the VITEK\u00ae REVEAL\u2122 versus the VITEK2 system in susceptibility testing of NDM-producing enterobacterales and Acinetobacter baumannii directly from positive blood cultures"],"prefix":"10.1007","volume":"44","author":[{"given":"Ohad","family":"Shalom","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inbar","family":"Cohen-Lerner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amos","family":"Adler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,18]]},"reference":[{"key":"5219_CR1","doi-asserted-by":"publisher","first-page":"4851","DOI":"10.1128\/AAC.00627-10","volume":"54","author":"M Paul","year":"2010","unstructured":"Paul M, Shani V, Muchtar E, Kariv G, Robenshtok E, Leibovici L (2010) Systematic review and meta-analysis of the efficacy of appropriate empiric antibiotic therapy for sepsis. Antimicrob Agents Chemother 54:4851\u20134863","journal-title":"Antimicrob Agents Chemother"},{"key":"5219_CR2","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1016\/j.cmi.2019.09.023","volume":"1","author":"DR Giacobbe","year":"2020","unstructured":"Giacobbe DR, Giani T, Bassetti M, Marchese A, Viscoli C, Rossolini GM (2020) Rapid Microbiological tests for bloodstream infections due to multidrug resistant Gram-negative bacteria: therapeutic implications. Clin Microbiol Infect 1:26:713\u2013722","journal-title":"Clin Microbiol Infect"},{"key":"5219_CR3","unstructured":"Zhen X, St\u00e5lsby Lundborg C, Sun X, Zhu N, Gu S, Dong H (2019) Antibiotic resistance threats in the United States, 2019. Atlanta, Georgia"},{"key":"5219_CR4","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1017\/ice.2019.282","volume":"41","author":"DR Budhram","year":"2020","unstructured":"Budhram DR, Mac S, Bielecki JM, Patel SN, Sander B (2020) Health outcomes attributable to carbapenemase-producing Enterobacteriaceae infections: A systematic review and meta-analysis. Infect Control Hosp Epidemiol 41:37\u201343","journal-title":"Infect Control Hosp Epidemiol"},{"key":"5219_CR5","doi-asserted-by":"publisher","first-page":"e00115","DOI":"10.1128\/CMR.00115-18","volume":"32","author":"W Wu","year":"2019","unstructured":"Wu W, Feng Y, Tang G, Qiao F, McNally A, Zong Z (2019) NDM Metallo- \u03b2-Lactamases and their bacterial producers in healthcare settings. Clin Microbiol Rev 32:e00115\u2013e00118","journal-title":"Clin Microbiol Rev"},{"key":"5219_CR6","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1080\/14787210.2023.2216455","volume":"3","author":"S Reich","year":"2023","unstructured":"Reich S, Adler A (2023) Introduction and spread of NDM-producing enterobacterales and Acinetobacter baumannii into middle Eastern countries: a molecular-based hypothesis. Expert Rev Anti Infect Ther 3:21:749\u2013758","journal-title":"Expert Rev Anti Infect Ther"},{"key":"5219_CR7","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1089\/mdr.2016.0330","volume":"24","author":"A Adler","year":"2018","unstructured":"Adler A, Glick R, Lifshitz Z, Carmeli Y (2018) Does Acinetobacter baumannii serve as a source for BlaNDM dissemination into Enterobacteriaceae in hospitalized patients?? Microb Drug Resist 24:150\u2013153","journal-title":"Microb Drug Resist"},{"key":"5219_CR8","doi-asserted-by":"crossref","unstructured":"Adler A, Ghosh H, Gross A, Rechavi A, Lasnoy M, Assous MV et al (2023) Clinical and molecular features of NDM-producing Acinetobacter baumannii in a multicenter study in Israel. Ann Clin Microbiol Antimicrob 122","DOI":"10.1186\/s12941-023-00607-w"},{"key":"5219_CR9","doi-asserted-by":"crossref","unstructured":"Tibbetts R, George S, Burwell R, Rajeev L, Rhodes PA, Singh P et al (2022) Performance of the reveal rapid antibiotic susceptibility testing system on Gram-Negative blood cultures at a large urban hospital. J Clin Microbiol 160","DOI":"10.1128\/jcm.00098-22"},{"key":"5219_CR10","doi-asserted-by":"crossref","unstructured":"Bianco G, Boattini M, Comini S, Bondi A, Curtoni A, Piccinini G et al Detection of volatile organic compounds as new paradigm to accelerate antimicrobial susceptibility testing: performance evaluation of VITEK\u00ae REVEAL\u2122. J Antimicrob Chemother 2024 1;79:2237\u20132245","DOI":"10.1093\/jac\/dkae219"},{"key":"5219_CR11","unstructured":"Williams E, Fowler J, Gray M, Tovey M, Rayworth N, Tilley L et al Use of the reveal rapid antimicrobial susceptibility testing system to shorten time to appropriate antibiotic use: assessment of clinical utility in Sheffield teaching hospitals NHS trust"},{"key":"5219_CR12","doi-asserted-by":"crossref","unstructured":"Adler A, Ghosh H, Gross A, Rechavi A, Lasnoy M, Assous MV et al Molecular features and transmission of NDM-producing enterobacterales in Israeli hospitals. J Antimicrob Chemother 2023 2;78:719\u2013723","DOI":"10.1093\/jac\/dkad001"},{"key":"5219_CR13","unstructured":"EUCAST Breakpoint Tables [Internet] doi: http:\/\/www.eucast.org"},{"key":"5219_CR14","doi-asserted-by":"crossref","unstructured":"Hombach M, B??ttger EC, Roos M (2013) The critical influence of the intermediate category on interpretation errors in revised EUCAST and CLSI antimicrobial susceptibility testing guidelines. Clin Microbiol Infect;19","DOI":"10.1111\/1469-0691.12090"},{"key":"5219_CR15","doi-asserted-by":"crossref","unstructured":"Girlich D, Jousset AB, Emeraud C, Rezzoug I, Burwell R, Singh P et al Evaluation of the Reveal\u00ae AST (SPECIFIC) for Antimicrobial Susceptibility Testing from Positive Blood Culture Spiked with Carbapenem-Resistant Isolates. Pathogens 2024 27;13:722.","DOI":"10.3390\/pathogens13090722"},{"key":"5219_CR16","doi-asserted-by":"crossref","unstructured":"Lee ALH, Leung ECM, Chow VCY (2024) Comparison of carbapenem MIC for NDM-producing enterobacterales by different AST methods. JAC Antimicrob Resist 1;6.","DOI":"10.1093\/jacamr\/dlae028"},{"key":"5219_CR17","doi-asserted-by":"crossref","unstructured":"Nana T, Perovic O, Chibabhai V (2022) Comparison of carbapenem minimum inhibitory concentrations of Oxacillin-48-like Klebsiella pneumoniae by Sensititre, Vitek 2, MicroScan, and Etest. Clinical Microbiology and Infection 1;28:1650.e1-1650.e5","DOI":"10.1016\/j.cmi.2022.06.023"}],"container-title":["European Journal of Clinical Microbiology & Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-025-05219-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10096-025-05219-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-025-05219-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T13:45:43Z","timestamp":1759239943000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10096-025-05219-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,18]]},"references-count":17,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["5219"],"URL":"https:\/\/doi.org\/10.1007\/s10096-025-05219-0","relation":{},"ISSN":["0934-9723","1435-4373"],"issn-type":[{"value":"0934-9723","type":"print"},{"value":"1435-4373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,18]]},"assertion":[{"value":"2 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Microbiological study not involving human data or samples.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}